Bioengineered Skin Substitutes Market

Bioengineered skin consists of the outer epidermis and/or dermis (the layer of skin between the epidermis and subcutaneous tissue) embedded in an acellular matrix (supporting structure) to form a biological skin substitute. Products are made from a variety of sources, including human tissue (from patients or others), non-human tissue (bovine, porcine, horse), synthetic materials (man-made), or a combination of these materials.
Bioengineered Skin Substitutes Market contains market size and forecasts of Bioengineered Skin Substitutes in Global, including the following market information:
Global Bioengineered Skin Substitutes Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Bioengineered Skin Substitutes market was valued at 1507.6 million in 2021 and is projected to reach US$ 3190.3 million by 2028, at a CAGR of 11.3% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Allogeneic Acellular Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bioengineered Skin Substitutes include Allergan (AbbVie), AlloSource, Organogenesis, BD, Smith & Nephew, Integra LifeSciences, Synthes (Johnson & Johnson), Axogen and Vericel Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Bioengineered Skin Substitutes companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bioengineered Skin Substitutes Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Bioengineered Skin Substitutes Market Segment Percentages, by Type, 2021 (%)
Allogeneic Acellular
Xenogeneic
Allogeneic Cells
Autologous
Global Bioengineered Skin Substitutes Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Bioengineered Skin Substitutes Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Wound Care Centers
Global Bioengineered Skin Substitutes Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Bioengineered Skin Substitutes Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bioengineered Skin Substitutes revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Bioengineered Skin Substitutes revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan (AbbVie)
AlloSource
Organogenesis
BD
Smith & Nephew
Integra LifeSciences
Synthes (Johnson & Johnson)
Axogen
Vericel Corporation
LifeNet Health
MTF Biologics
Arthrex
Wright Medical Group NV (Stryker)
Cook Biotech Incorporated
Aroa Biosurgery
Surgalign Holdings
Anika Therapeutics
Forticell Bioscience
MLM Biologics
Promethean LifeSciences